Lutris Pharma Ltd.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC (NCT04759664) | Lutris Pharma Ltd. | 2021-04-12 |
| LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients (NCT04261387) | Lutris Pharma Ltd. | 2021-01-30 |
| A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions (NCT03876106) | Lutris Pharma Ltd. | 2019-08-21 |
Track Lutris Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.